68例EGFR突变型肺腺癌脑转移患者早期颅脑放疗对比延迟放疗疗效分析  

Efficacy analysis of early radiotherapy versus delayed radiotherapy in 68 cases of EGFR-mutant lung adenocarcinoma with brain metastases

作　　者：钱晶 何泽来 田校源 景齐骏 李红伟[1] QIAN Jing;HE Ze-lai;TIAN Xiao-yuan;JING Qi-jun;LI Hong-wei(Department of Radiation Oncology,the First Affiliated Hospital of Bengbu Medical College,Bengbu,Anhui 233000,China;不详)

机构地区：[1]蚌埠医学院第一附属医院肿瘤放疗科,安徽蚌埠233000 [2]大连医科大学附属第二医院肿瘤放疗科,辽宁大连116000

出　　处：《中华全科医学》2021年第12期1995-1998,2027,共5页Chinese Journal of General Practice

基　　金：国家自然科学基金项目(81602727);蚌埠医学院自然科学重点项目(BYKY2019097ZD)。

摘　　要：目的探讨早期放疗与延迟放疗对EGFR突变型肺腺癌合并脑转移患者的疗效和影响因素。方法收集2016年1月1日—2020年12月31日就诊于蚌埠医学院第一附属医院的68例EGFR突变型肺腺癌脑转移患者的资料。根据脑放疗时机将患者分为2组,早期放疗组48例:脑部放疗同步表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKIs);延迟放疗组20例:先行EGFR-TKIs治疗,脑部病灶进展后行颅脑放疗。评估2组患者颅内无进展生存时间(iPFS)和总生存时间(OS),同时行预后影响因素分析。结果所有患者的中位OS为26个月。早期放疗组比延迟放疗组的iPFS有延长趋势,1年、2年、3年iPFS率分别为91.3%、73.5%、61.3%和74.3%、60.8%、30.4%(P=0.078);早期放疗组比延迟放疗组的OS也呈延长趋势,1年、2年、3年的OS率分别为81.6%、51.5%、51.5%和65.0%、51.2%、20.5%,但差异均无统计学意义(P=0.321)。多因素分析显示Lung-mol GPA评分高(2.5~4.0分)的患者OS明显优于评分低(0~2.0分)的患者(P<0.001);ECOG评分低与更好的iPFS相关(P=0.010)。结论EGFR突变型脑转移患者的早期颅脑放疗对比延迟放疗,iPFS和OS有延长趋势,但差异无统计学意义。ECOG评分和Lung-mol GPA评分分别为iPFS和OS的独立预后因素。Objective To investigate the efficacy and influencing factors of early radiotherapy versus delayed radiotherapy in EGFR-mutant lung adenocarcinoma patients with brain metastasis.Methods A total of 68 cases of EGFR-mutant lung adenocarcinoma patients with brain metastases,who were admitted in the First Affiliated Hospital of Bengbu Medical College from January 1,2016 to December 31,2020.The patients were divided into two groups according to the timing of brain radiotherapy.The early radiotherapy group(n=48)received brain radiotherapy and epidermal growth factor receptor tyrosine kinase inhibitor(EGFR-TKI)simultaneously.In the delayed radiotherapy group(n=20),EGFR-TKI was performed initially,and brain radiotherapy was performed after the brain lesions progressed.Intracranial progression-free survival(iPFS)and overall survival(OS)of the two groups were evaluated,and prognostic factors were analysed.Results The median OS of all patients was 26 months.The iPFS of the early radiotherapy group was prolonged compared with the delayed group.The 1-year,2-year and 3-year iPFS rates were 91.3%,73.5%,61.3%and 74.3%,60.8%,30.4%,respectively(P=0.078).The OS of the early radiotherapy group was also longer than that of the delayed radiotherapy group.The OS rates were 81.6%,51.5%,51.5%and 65.0%,51.2%,20.5%,respectively,with no significant difference(P=0.321).The OS of patients with high Lung-mol GPA score was better than the OS of patients with low score(P<0.001).Low ECOG score indicated good iPFS(P=0.010).Conclusion Compared with delayed radiotherapy,early radiotherapy may prolong iPFS and OS,but no significant statistical difference is found.ECOG and Lung-mol GPA are independent prognostic factors of iPFS and OS,respectively.

关 键 词：肺腺癌 脑转移 酪氨酸激酶抑制剂 脑放疗 

分 类 号：R734.2[医药卫生—肿瘤] R730.55[医药卫生—临床医学]